INS and depressive symptom measurement: A significant increase after admission was observed for many cardiovascular or neurovascular disease (45% to 51%), dementia (35% to 47%), and also for insulin-treated diabetics (5% to 6%), depression and other mood disorders (5% to 6%), Parkinson’s disease (6% to 7%) and chronic respiratory disease (11% to 13%).